Table 2.
Safety issues in gene therapy products using genome-editing techniques
| • Off-target effects |
| • On-target mutagenesis |
| • Chromosomal changes (translocation/inversion/deletion) |
| • P53 mutation |
| • Immunogenicity of nucleases |
| • Germline modification |